Ribavirin
Ribavirin is a broad-spectrum antiviral medicine used in selected viral infections, including certain cases of chronic hepatitis C in combination with other antivirals and specific respiratory syncytial virus (RSV) infections in high-risk patients. It works by interfering with viral RNA synthesis and replication through effects on viral nucleotide metabolism and RNA polymerase activity. Depending on the indication, it may be available as oral capsules or tablets, an oral solution, or an inhalation formulation. Common side effects include fatigue, nausea, headache, and haemolytic anaemia, which may require regular blood-count monitoring. A major safety concern is its risk of causing severe birth defects and pregnancy loss; it is contraindicated during pregnancy, and strict pregnancy-prevention measures are required for patients and, in relevant circumstances, their partners. Ribavirin should be used only under specialist supervision, with monitoring of blood counts, kidney function, and treatment-specific risks.
Ribavirin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Ribavirin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Ribavirin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Ribavirin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
